DURECT Corporation To Present At The NewsMakers In The Biotech Industry Investment Conference
Cupertino, CA-
August 31, 2007
CUPERTINO, CA, August 29, 2007/ PRNewswire-First Call via COMTEX/ -- DURECT Corporation (Nasdaq: DRRX) announced today that James E. Brown, President and CEO, will be presenting at the NewsMakers in the Biotech Industry Investment Conference to be held in New York City on September 6, 2007 at 11:30 a.m. Eastern Time.
A live audio webcast of the presentation will be available by accessing DURECT’s homepage at www.durect.com and clicking “Investor Relations.” If you are unable to participate during the live webcast, the call will be archived on DURECT’s website under Audio Archive in the “Investor Relations” section.
About DURECT Corporation
DURECT Corporation is an emerging specialty pharmaceutical company developing pharmaceutical systems based on its proprietary drug delivery platform technologies. The Company currently has a number of late-stage pharmaceutical products in development addressing large markets in pain management, with a number of research programs underway targeting chronic disease and other therapeutic areas. For more information, please visit www.durect.com.
SOURCE: DURECT Corporation CONTACT: Matthew J. Hogan, Chief Financial Officer, 408-777-4936
|
|
